Related Experiment Video
Updated: Jan 31, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome
Adam Evans1, Michael T McCurdy2, Menachem Weiner3
1Department of Anesthesiology, Morristown Medical Center, Morristown, New Jersey.
Abstract:
Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post-cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.
Related Concept Videos
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiopulmonary Resuscitation II: ACLS Airway Management

